Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.8597
-0.0203 (-2.31%)
At close: May 18, 2026, 4:00 PM EDT
0.8350
-0.0247 (-2.87%)
After-hours: May 18, 2026, 4:53 PM EDT

Valion Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7.2212.6523.43.5212.98
Cash & Short-Term Investments
7.2212.6523.43.5212.98
Cash Growth
978.48%531.62%-41.03%-3.47%-72.89%1142.82%
Accounts Receivable
---0.170.110.09
Inventory
0.75--0.760.860.43
Other Current Assets
1.610.50.690.330.820.79
Total Current Assets
8.6513.012.644.655.3114.29
Net Property, Plant & Equipment
22.7312.6400.470.540.7
Other Intangible Assets
2.242.24----
Goodwill
3.463.46----
Other Long-Term Assets
0.210.120.120.030.030.05
Total Assets
38.2231.612.815.165.8815.04
Accounts Payable
0.630.260.130.711.320.79
Accrued Expenses
1.490.380.130.50.390.27
Current Portion of Leases
0.49--0.190.160.16
Other Current Liabilities
00.010.02---
Total Current Liabilities
2.620.650.271.41.881.22
Long-Term Debt
6.96.45----
Long-Term Leases
9.64--0.180.370.55
Other Long-Term Liabilities
0.510.34----
Total Long-Term Liabilities
17.056.79-0.180.370.55
Total Liabilities
19.677.440.271.582.251.76
Common Stock
000--0
Additional Paid-in Capital
70.0969.3946.0841.4733.2732.82
Retained Earnings
-59.03-52.6-43.54-37.89-29.64-19.55
Total Common Shareholders' Equity
11.0616.82.543.583.6313.27
Minority Interest
7.497.37----
Shareholders' Equity
18.5524.172.543.583.6313.27
Total Liabilities & Equity
38.2231.612.815.165.8815.04
Total Debt
17.036.4500.370.530.71
Net Cash (Debt)
-9.826.1923.032.9912.27
Net Cash Growth
-209.24%-33.84%1.31%-75.65%-
Net Cash Per Share
-5.675.366.9764.87104939.201193949.95
Book Value
11.0616.82.543.583.6313.27
Book Value Per Share
6.3914.548.8276.74127529.001291760.00
Tangible Book Value
5.3611.12.543.583.6313.27
Tangible Book Value Per Share
3.109.608.8276.74127529.001291760.00
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q